SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (2165)7/31/2017 1:10:05 PM
From: DewDiligence_on_SI  Read Replies (2) | Respond to of 3559
 
Have you seen the commercial-uptake chart for Eliquis? In early quarters, it looked like a dud; however, in 2Q17 it had an annualized rate of $4.7B (+51% YoY).

Rituxan is another example from the more distant past.